Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$0.70
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 18, 2026 | $-0.01 | $-0.07 | Miss -600.0% | $-0.07 | $13.6M | $12.6M | -7.4% | 1D Pre+2.8% | On-Day+5.7% | 1D Post-15.8% |
Q ended Mar 31, 2026 Reported May 19, 2026 | $-0.07 | $-0.03 | Beat +57.1% | $-0.03 | $11.9M | $11.8M | -0.8% | 1D Pre+0.5% | On-Day+3.4% | 1D Post-4.8% |
Q ended Dec 31, 2025 Reported Mar 26, 2026 | $-0.02 | $-0.01 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| — |
| $14.7M |
| — |
| 1D Pre-1.9% |
| On-Day+1.9% |
| 1D Post-26.7% |
Q ended Sep 30, 2025 Reported Nov 11, 2025 | $-0.06 | $-0.09 | Miss -50.0% | — | — | $12.5M | — | 1D Pre+4.3% | On-Day+8.2% | 1D Post-19.8% |